
Sign up to save your podcasts
Or


This product GTTS-WQ17MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the monoclonal antibody that targets S gene. The antibody can be applied in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) research. https://mrna.creative-biolabs.com/ivtscrip-mrna-anti-s-2130-cap-0-5-methyl-ctp-pseudo-utp-30-nt-poly-a-27.htm
This product GTTS-WQ16MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the monoclonal antibody that targets S gene. The antibody can be applied in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) research. https://mrna.creative-biolabs.com/ivtscrip-mrna-anti-s-2130-cap-1-5-methyl-ctp-pseudo-utp-120-nt-poly-a-26.htm
This product GTTS-WQ15MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the monoclonal antibody that targets S gene. The antibody can be applied in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) research. https://mrna.creative-biolabs.com/ivtscrip-mrna-anti-s-2130-cap-0-5-methyl-ctp-pseudo-utp-120-nt-poly-a-25.htm
This product GTTS-WQ14MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the monoclonal antibody that targets S gene. The antibody can be applied in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) research. https://mrna.creative-biolabs.com/ivtscrip-mrna-anti-s-2130-cap-1-n1-methylpseudo-utp-30-nt-poly-a-24.htm
This product GTTS-WQ13MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the monoclonal antibody that targets S gene. The antibody can be applied in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) research. https://mrna.creative-biolabs.com/ivtscrip-mrna-anti-s-2130-cap-0-n1-methylpseudo-utp-30-nt-poly-a-23.htm
This product GTTS-WQ12MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the monoclonal antibody that targets S gene. The antibody can be applied in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) research. https://mrna.creative-biolabs.com/ivtscrip-mrna-anti-s-2130-cap-1-n1-methylpseudo-utp-120-nt-poly-a-22.htm
There is an emerging appreciation of the existence of RNA repair pathways that rely on mRNA ligases to maintain or manipulate mRNA structure in response to purposeful mRNA breakage events. mRNA ligase is RNA repair enzymes capable of sealing breaks. The mRNA ligase can be served for joining mRNA to mRNA. Creative Biolabs offers the most extensive selection of high-quality and performance-optimized RNA ligases and masters mixes to streamline your experiments. The pre-mixed, ready-to-use formulations include a proprietary ligation reaction enhancement agent for improved performance.
RNase is an endoribonuclease that cleaves single-stranded RNA. It catalyzes the cleavage of the phosphodiester bond between the 5'-ribose of a nucleotide and the phosphate group attached to the 3'-ribose of an adjacent pyrimidine nucleotide. This cleavage forms a 2',3'-cyclic phosphate, which is then hydrolyzed to the corresponding 3'-nucleoside phosphate.
mRNA polymerase is a DNA-dependent mRNA polymerase that is used for in vitro mRNA synthesis with strict specificity for its respective double-stranded promoters. Large quantities of RNA can be synthesized from a DNA sequence cloned downstream under the promoters due to the high processivity and transcription frequency of mRNA polymerase. RNA produced using the mRNA polymerase is suitable for many applications in research and biotechnology, including radiolabeled RNA probe preparation, mRNA for in vitro translation and microinjection, RNA structure, processing, and catalysis studies, RNA amplification, and expression control via anti-sense RNA.
mRNA polymerase, RNase & inhibitors, mRNA ligase, mRNA reverse transcriptase, and mRNA capping
From the publisher's feed